These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 12200684)
1. Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy. Boissel N; Cayuela JM; Preudhomme C; Thomas X; Grardel N; Fund X; Tigaud I; Raffoux E; Rousselot P; Sigaux F; Degos L; Castaigne S; Fenaux P; Dombret H Leukemia; 2002 Sep; 16(9):1699-704. PubMed ID: 12200684 [TBL] [Abstract][Full Text] [Related]
2. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Whitman SP; Archer KJ; Feng L; Baldus C; Becknell B; Carlson BD; Carroll AJ; Mrózek K; Vardiman JW; George SL; Kolitz JE; Larson RA; Bloomfield CD; Caligiuri MA Cancer Res; 2001 Oct; 61(19):7233-9. PubMed ID: 11585760 [TBL] [Abstract][Full Text] [Related]
3. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Jilani I; Estey E; Manshuri T; Caligiuri M; Keating M; Giles F; Thomas D; Kantarjian H; Albitar M Leukemia; 2003 Jan; 17(1):114-9. PubMed ID: 12529667 [TBL] [Abstract][Full Text] [Related]
4. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway. Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110 [TBL] [Abstract][Full Text] [Related]
5. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Moreno I; Martín G; Bolufer P; Barragán E; Rueda E; Román J; Fernández P; León P; Mena A; Cervera J; Torres A; Sanz MA Haematologica; 2003 Jan; 88(1):19-24. PubMed ID: 12551822 [TBL] [Abstract][Full Text] [Related]
6. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome. Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908 [TBL] [Abstract][Full Text] [Related]
7. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041 [TBL] [Abstract][Full Text] [Related]
8. Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16). Kainz B; Heintel D; Marculescu R; Schwarzinger I; Sperr W; Le T; Weltermann A; Fonatsch C; Haas OA; Mannhalter C; Lechner K; Jaeger U Hematol J; 2002; 3(6):283-9. PubMed ID: 12522450 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H; Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients. Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064 [TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication. Muñoz L; Aventín A; Villamor N; Juncà J; Acebedo G; Domingo A; Rozman M; Torres JP; Tormo M; Nomdedéu JF Haematologica; 2003 Jun; 88(6):637-45. PubMed ID: 12801839 [TBL] [Abstract][Full Text] [Related]
12. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation. Yoshimoto G; Nagafuji K; Miyamoto T; Kinukawa N; Takase K; Eto T; Kato K; Hayashi S; Kamimura T; Ohno Y; Taniguchi S; Harada M Bone Marrow Transplant; 2005 Dec; 36(11):977-83. PubMed ID: 16184177 [TBL] [Abstract][Full Text] [Related]
13. Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Noguera NI; Breccia M; Divona M; Diverio D; Costa V; De Santis S; Avvisati G; Pinazzi MB; Petti MC; Mandelli F; Lo Coco F Leukemia; 2002 Nov; 16(11):2185-9. PubMed ID: 12399960 [TBL] [Abstract][Full Text] [Related]
14. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis. Brunet S; Labopin M; Esteve J; Cornelissen J; Socié G; Iori AP; Verdonck LF; Volin L; Gratwohl A; Sierra J; Mohty M; Rocha V J Clin Oncol; 2012 Mar; 30(7):735-41. PubMed ID: 22291086 [TBL] [Abstract][Full Text] [Related]
15. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia. Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718 [TBL] [Abstract][Full Text] [Related]
16. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia. How J; Sykes J; Gupta V; Yee KW; Schimmer AD; Schuh AC; Minden MD; Kamel-Reid S; Brandwein JM Cancer; 2012 Dec; 118(24):6110-7. PubMed ID: 22736495 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of FLT3 ITD and D835 mutations in AML patients. Sheikhha MH; Awan A; Tobal K; Liu Yin JA Hematol J; 2003; 4(1):41-6. PubMed ID: 12692519 [TBL] [Abstract][Full Text] [Related]
18. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia. Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077 [TBL] [Abstract][Full Text] [Related]
19. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation. Jiang A; Jiang H; Brandwein J; Kamel-Reid S; Chang H Leuk Res; 2011 Apr; 35(4):492-8. PubMed ID: 20684989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]